News Release
Home
News Release
- 2023.09.20 Research and Development
- Notification regarding Skin Care Cosmetics with Microneedle Technology
- 2023.09.19 Research and Development
- Notification of the commencement of the Phase II clinical study of HP-6050 in Japan (a transdermal formulation for sedation)
- 2023.09.04 lR Information
- Notice Regarding Status of Acquisition of Treasury Shares
- 2023.08.28 Other
- Products to solve issues for living in Space and living on Earth “Odorleship®” Notification to be used in the International Space Station
- 2023.08.03 lR Information
- Notice Regarding Status of Acquisition of Treasury Shares
- 2023.07.31 Other
- Notice regarding Determination of Details of Issuance of Stock Compensation-Type Share Options (Stock Acquisition Rights)
- 2023.07.27 Other
- Notice regarding Providing Relief Supplies in Response to the Torrential Rains from July 7, 2023
- 2023.07.13 lR Information
- Notice Regarding Company Split (Simplified Absorption-Type Split) with Hisamitsu Wellness Co., Ltd.
- 2023.07.13 lR Information
- Notice regarding Issuance of Stock Compensation-Type Share Options(Stock Acquisition Rights)
- 2023.07.13 lR Information
- Notification Regarding Concerning the Decision of Matters Relating to Acquisition of Company’s Own Shares
- 2023.07.13 lR Information
- Conclusion of a contract with SSP Co., Ltd. for the partial transfer of assets, related to S-Cup and Lacalut
- 2023.07.13 lR Information
- FY02/2024 Q1 Results Earnings Release Presentation
- 2023.06.14 Other
- “MOHRUS® TAPE 20mg,” “MOHRUS® TAPE L 40mg”Announcement of our wining 47th Kinoshita Prize for “Packaging Technology”
- 2023.05.24 Ethical Drugs
- APOHIDE® Lotion 20%, a Primary Palmar Hyperhidrosis Treatment Drug, Is Now Available for Sale
- 2023.05.18 Other
- Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Seventh Consecutive Year
- 2023.04.13 Management and Personnel
- Executive Appointments
- 2023.04.13 lR Information
- FY02/2023 Q4 Results Earnings Release Presentation
- 2023.03.30 lR Information
- Notice regarding Revision of Earnings Forecast
- 2023.03.27 Ethical Drugs
- Notification of approval for manufacturing and marketing approval of APOHIDE® Lotion 20% in Japan(Primary palmar hyperhidrosis treatment drug, development code: HP-5070)
- 2023.03.20 Other
- Establishment of a new R&D center inside Shonan iPark
- 2023.03.14 Other
- JLPGA Step Up Tour Notice of the New Salonpas Ladies’Open to Be Held
- 2023.02.22 Other
- Notice regarding Support for the Earthquake in Turkey and Syria
- 2023.02.13 lR Information
- Notice regarding Results and Completion of Acquisition of Treasury Shares
- 2023.01.12 lR Information
- FY02/2023 Q3 Results Earnings Release Presentation
